Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dunn

Showing results (801-810 of 961) with videos related to

Pageof 97
Sort By:
Diabetes, Obesity & Metabolism|February 4, 2026
A treat-to-target approach for obesity management: A post hoc analysis of the SURMOUNT-5 trialCarel W le Roux, Luca Busetto, Louis Aronne, et al.
American Journal of Ophthalmology|August 30, 2021
Endophthalmitis After Intravitreal Anti-Vascular Endothelial Factor Injections: Outcomes of Eyes Managed Without Microbiologic CulturesSamir N Patel, Louis Z Cai, Raziyeh Mahmoudzadeh, et al.
The Journal of Experimental Medicine|September 21, 2011
Type I interferon is selectively required by dendritic cells for immune rejection of tumorsMark S Diamond, Michelle Kinder, Hirokazu Matsushita, et al.
Ocular Immunology and Inflammation|February 21, 2023
Glaucoma Surgical Outcomes in Patients with a History of ScleritisJae-Chiang Wong, Esika Savsani, Raziyeh Mahmoudzadeh, et al.
Ophthalmology. Retina|June 30, 2020
Endophthalmitis after Cataract Surgery: Changes in Management Based on Microbiologic CulturesSamir N Patel, Philip P Storey, Hannah Levin, et al.
Nature Immunology|June 14, 2005
A critical function for type I interferons in cancer immunoeditingGavin P Dunn, Allen T Bruce, Kathleen C F Sheehan, et al.
The New England Journal of Medicine|May 12, 2025
Tirzepatide as Compared with Semaglutide for the Treatment of ObesityLouis J Aronne, Deborah Bade Horn, Carel W le Roux, et al.
Ophthalmology|April 28, 2009
Recipient risk factors for graft failure in the cornea donor studyAlan Sugar, Jean Paul Tanner, Mariya Dontchev, et al.
Cancer Discovery|September 30, 2016
Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade ImmunotherapyTanner M Johanns, Christopher A Miller, Ian G Dorward, et al.
Neuro-Oncology|March 6, 2020
Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccineConnor J Liu, Maximilian Schaettler, Dylan T Blaha, et al.
Pageof 97

Showing results (801-810 of 961) with videos related to

Sort By:
Pageof 97
Diabetes, Obesity & Metabolism|February 4, 2026
A treat-to-target approach for obesity management: A post hoc analysis of the SURMOUNT-5 trialCarel W le Roux, Luca Busetto, Louis Aronne, et al.
American Journal of Ophthalmology|August 30, 2021
Endophthalmitis After Intravitreal Anti-Vascular Endothelial Factor Injections: Outcomes of Eyes Managed Without Microbiologic CulturesSamir N Patel, Louis Z Cai, Raziyeh Mahmoudzadeh, et al.
The Journal of Experimental Medicine|September 21, 2011
Type I interferon is selectively required by dendritic cells for immune rejection of tumorsMark S Diamond, Michelle Kinder, Hirokazu Matsushita, et al.
Ocular Immunology and Inflammation|February 21, 2023
Glaucoma Surgical Outcomes in Patients with a History of ScleritisJae-Chiang Wong, Esika Savsani, Raziyeh Mahmoudzadeh, et al.
Ophthalmology. Retina|June 30, 2020
Endophthalmitis after Cataract Surgery: Changes in Management Based on Microbiologic CulturesSamir N Patel, Philip P Storey, Hannah Levin, et al.
Nature Immunology|June 14, 2005
A critical function for type I interferons in cancer immunoeditingGavin P Dunn, Allen T Bruce, Kathleen C F Sheehan, et al.
The New England Journal of Medicine|May 12, 2025
Tirzepatide as Compared with Semaglutide for the Treatment of ObesityLouis J Aronne, Deborah Bade Horn, Carel W le Roux, et al.
Ophthalmology|April 28, 2009
Recipient risk factors for graft failure in the cornea donor studyAlan Sugar, Jean Paul Tanner, Mariya Dontchev, et al.
Cancer Discovery|September 30, 2016
Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade ImmunotherapyTanner M Johanns, Christopher A Miller, Ian G Dorward, et al.
Neuro-Oncology|March 6, 2020
Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccineConnor J Liu, Maximilian Schaettler, Dylan T Blaha, et al.
Pageof 97